Quantcast

Posts related to ‘colorectal cancer’

biotech

ArQule Fails in Colorectal Cancer Trials

Posted: January 11, 2013 at 9:09 am

ArQule Inc. (NASDAQ: ARQL) is about to lose some serious hope for investors. It and Daiichi Sankyo announced that the top-line results of phase 2 trial with tivantinib in colorectal cancer did not meet ...
Read Full Story »

FDA Gives Nod to Onyx and Bayer for Stivarga in Gastrointestinal Tumors

Posted: October 29, 2012 at 11:58 am

There is some potentially very good news for those with gastrointestinal stromal tumors. The FDA has granted a priority review to the New Drug Application of Bayer HealthCare and Onyx ...
Read Full Story »